天堂国产午夜亚洲专区-少妇人妻综合久久蜜臀-国产成人户外露出视频在线-国产91传媒一区二区三区

當(dāng)前位置:主頁(yè) > 醫(yī)學(xué)論文 > 腫瘤論文 >

膠質(zhì)瘤化療現(xiàn)狀與展望

發(fā)布時(shí)間:2018-04-27 15:35

  本文選題:膠質(zhì)瘤細(xì)胞 + 惡性膠質(zhì)瘤; 參考:《廣東醫(yī)學(xué)》2017年01期


【摘要】:正神經(jīng)膠質(zhì)瘤是中樞神經(jīng)系統(tǒng)最常見(jiàn)原發(fā)性腫瘤,占顱內(nèi)腫瘤的40%以上。在15歲以下兒童和15~34歲成年人群的癌癥死亡患者中,腦膠質(zhì)瘤是第二大原因。腦膠質(zhì)瘤,特別是高級(jí)別膠質(zhì)瘤(WHO分類Ⅲ~Ⅳ級(jí)腫瘤,也稱惡性膠質(zhì)瘤)發(fā)病多在青壯年,治療困難,預(yù)后差。目前,惡性膠質(zhì)瘤
[Abstract]:Positive glioma is the most common primary tumor in the central nervous system, accounting for more than 40% of intracranial tumors. Gliomas are the second leading cause of cancer deaths among children under 15 and adults aged 15-34. Brain gliomas, especially high-grade gliomas, are classified by WHO as grade 鈪,

本文編號(hào):1811298

資料下載
論文發(fā)表

本文鏈接:http://sikaile.net/yixuelunwen/zlx/1811298.html


Copyright(c)文論論文網(wǎng)All Rights Reserved | 網(wǎng)站地圖 |

版權(quán)申明:資料由用戶8f92b***提供,本站僅收錄摘要或目錄,作者需要?jiǎng)h除請(qǐng)E-mail郵箱bigeng88@qq.com